Evaluación de inmunoglobulinas como tratamiento alternativo de parvovirosis en caninos

Canine parvovirus is a highly contagious viral disease that affects dogs, with 80% of those infected recovering with treatment, although the mortality rate reaches 10%. The infection occurs mainly through contact with contaminated feces, which raises concern about outbreaks in vaccinated and adult dogs. In Ecuador, several outbreaks of parvovirus have been detected in dogs that have followed a complete vaccination schedule. The objectives of this research were: 1) To diagnose parvovirus using rapid tests, 2) To evaluate recovery times in patients with parvovirus using immunoglobulins as a therapeutic treatment, and 3) To assess the therapeutic response of immunoglobulins as a complementary treatment. The research was carried out in the Chambo canton, Chimborazo province, where the recovery time of 20 randomly selected canines was evaluated. The results showed that 85% of dogs had a heart rate between 90 and 140 bpm, while 15% had a heart rate above 140 bpm. Regarding respiratory rate, 90% had less than 10 bpm, and only 10% had higher rates. In addition, 75% of dogs had temperatures above 37 °C. Capillary refill time was normal in 80%, and most dogs (60%) had an average body condition score of 3/5, with 5% in optimal condition of 4/5. 90% of dogs responded favorably to treatment, with an average recovery time of 4 to 5 days in those treated with immunoglobulins, compared to 7 days for conventional treatment. Although no significant differences were observed in many parameters, treatment with immunoglobulins demonstrated an improvement in recovery and a reduction in mortality, suggesting a clinical benefit over conventional treatment.

• Auteur principal: Zúñiga Yasaca, Rita Alexandra (author)
• Format: bachelorThesis
• Publié: 2025
• Accès en ligne: https://dspace.ueb.edu.ec/handle/123456789/8106